Loading...

People

Loading...

Lisa Croen, PhD

Lisa Croen, PhD Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3463 (phone)
lisa.a.croen@kp.org

Lisa Croen, PhD, who joined the Division of Research as a perinatal epidemiologist in 2000, is a senior research scientist at the Division of Research, Kaiser Permanente Northern California, and the director of the Kaiser Permanente Autism Research Program. Her research interests include the epidemiology of autism and other neurodevelopmental disorders, environmental exposures and gene/environment interaction, and adverse perinatal outcomes. Currently, Dr. Croen is the site principal investigator on two large federally funded autism studies – the Study to Explore Early Development (SEED) and the Early Autism Risk Longitudinal Investigation Study (EARLI). She is also co-investigator on the California Autism Twins Study (CATS) and, in collaboration with clinical colleagues, directs the Kaiser Permanente site of the Autism Treatment Network and Autism Intervention Research Program. Dr. Croen received her master’s degree in public health and her doctorate in epidemiology, both from the University of California, Berkeley. Prior to coming to the Division of Research, she was an epidemiologist at the California Birth Defects Monitoring Program at the California Department of Health Services.

Current Position(s):

  • Research Scientist III, Division of Research, Kaiser Permanente Northern California
  • Director, Autism Research Program

Primary Research Interests:

  • Epidemiology of autism and neurodevelopmental disorders
  • Environmental exposures and gene/environment interactions

Related Web sites

Loading...

Diverse Autism Registry for Effectiveness Studies

The goal of the study is to create a large, comprehensive and dynamic autism spectrum disorder (ASD) registry across several integrated health systems.  The first phase of the study will look at variability across the participating health plans in the prevalence of ASD, in medical and psychiatric co-morbidities in the ASD population, and in the use of psychotropic medications to treat children and adolescents with ASDs.  The second phase will look at different treatment approaches, and treatment burdens for families of children with ASD, and parental perceptions of the efficacy of different treatments.  During the second phase of the study, parents of children diagnosed with an ASD who are Kaiser Permanente members will be invited to complete a Web survey and contribute a blood or saliva sample for future ASD research.
Funder: National Institute of Mental Health
Principal Investigator: Croen, Lisa

Loading...

Autism Blue Sky Conference

Funder: Garfield Memorial Fund
Principal Investigator: Croen, Lisa

Loading...

Prenatal and Neonatal Biologic Markers for Autism (EMA)

The proposed study will continue an investigation of prenatal and newborn biologic markers for autism previously funded by NIH. The goal of the new study is to further investigate the role of prenatal and newborn immunologic factors, genetic susceptibility factors, and environmental exposures by evaluating stored prenatal (maternal) and newborn blood specimens for children with autism, children with other developmental disabilities, and population controls.  We anticipate that the results of this study will contribute to identifying factors that increase the risk for autism and may lead to eventual prevention of autism and related disorders.
Funder: Nat. Inst. of Environmental Health Sciences
Principal Investigator: Croen, Lisa

Loading...

Environment, the Perinatal Epigenome and Risk for Autism and Related Disorders

This goal of this study is to understand the relationship between environmental exposures, epigenetics, and risk for autism. Our proposal will address four main themes: (1) the effects of pre and perinatal exposures on genome-wide methylation in mother, father, and child, (2) the familiality of DNAm and DNAm changes, (3) the effects of DNAm on child development and autism risk, and (4) the integration of GWAS SNP and CNV data already funded for this project with these epigenetic data to capture genetic and epigenetic effects in the epidemiology of autism.
Funder: National Cancer Institute
Principal Investigator: Croen, Lisa

Loading...

Prenatal and Neonatal Biologic Markers for Autism

The study will continue an investigation of prenatal and newborn biologic markers for autism previously funded by NIH. The goal of the new study is to further investigate the role of prenatal and newborn immunologic factors, genetic susceptibility factors, and environmental exposures by evaluating stored prenatal (maternal) and newborn blood specimens for children with autism, children with other developmental disabilities, and population controls.
Funder: Kaiser Foundation Health Plan
Principal Investigator: Croen, Lisa

Loading...

The IBIS-EARLI Collaboration

This proposal will form a collaboration between the EARLI Network and the IBIS Network, two Autism Centers of Excellence Networks focusing on the longitudinal study of high-risk siblings of children with autistic spectrum disorders.
Funder: Autism Speaks
Principal Investigator: Croen, Lisa

Loading...

Autism Intervention Research Network on Physical Health (AIR-P Network)

The AIR-P Network will: conduct research on evidence-based practices for interventions to improve the physical health and well-being of children and adolescents with ASD and other developmental disabilities; develop evidence-based guidelines and validate tools for interventions to improve the health care of children and adolescents with ASD and other developmental disabilities; and disseminate critical information on its research findings, guidelines developed, and validated tools to health professionals and the public, especially families impacted by ASD and other developmental disabilities.
Funder: Health Resources and Services Administration
Principal Investigator: Croen, Lisa

Loading...

Early Biologic Markers for Autism (EMA)

This case-control study of autism is examining several biologic markers of disease susceptibility and exposure in maternal blood specimens collected during midpregnancy and neonatal specimens collected at birth.
Funder: Autism Speaks
Principal Investigator: Croen, Lisa

Loading...

Early Autism Risks Longitudinal Investigation (EARLI) Network

This Autism Center of Excellence (ACE) Network is investigating possible risk factors and biologic indicators for autism spectrum disorders (ASD) during prenatal, neonatal, and early postnatal development. A prospective study will enroll 1,200 mothers of children with autism at the start of a new pregnancy and follow them and the new baby through 36 months post-delivery. 
Funder: Nat. Inst. of Environmental Health Sciences
Principal Investigator: Croen, Lisa

Loading...

Cooperative Multi-center Program for Research and Treatment of Autism (ATN)

This project aims to join the Autism Treatment Network, enroll a large sample of children with autism from the well-established programs at Kaiser Permanente, and advance the mission of combining outstanding research and clinical care by conducting studies to evaluate the use and effectiveness of medical treatments and complementary and alternative therapies, which have a high prevalence of use in this population.
Funder: Autism Speaks and Autism Treatment Network
Principal Investigator: Croen, Lisa

Loading...

California Monitoring of Early Childhood Autism (CA-MECA)

This study aims to find out what the prevalence of autism spectrum disorders is in children under the age of four in Santa Clara County.
Funder: CDC and CDHS
Principal Investigator: Croen, Lisa

Loading...

National CADDRE Study: Child Development and Autism (SEED)

This multi-site collaborative epidemiologic study investigates risk and causal factors for Autism Spectrum Disorders (ASD) and phenotypic subgroups of ASD using a population-based case-cohort study design.
Funder: Centers for Disease Control and Prevention
Principal Investigator: Croen, Lisa

Loading...

A California Population-based Twin Study of Autism (CATS)

The project aims to construct a large, population-based autism twin registry and to study the genetic influence on specific autism behavioral and cognitive characteristics and the relationships between these characteristics. 
Funder: National Institute of Mental Health
Principal Investigator: Croen, Lisa